Differential effects of FODMAPs (fermentable oligo-, di-, mono-saccharides and polyols) on small and large intestinal contents in healthy subjects shown by MRI

Kathryn Murray, Victoria Wilkinson-Smith, Caroline Hoad, Carolyn Costigan, Eleanor Cox, Ching Lam, Luca Marciani, Penny Gowland, Robin C Spiller, Kathryn Murray, Victoria Wilkinson-Smith, Caroline Hoad, Carolyn Costigan, Eleanor Cox, Ching Lam, Luca Marciani, Penny Gowland, Robin C Spiller

Abstract

Objectives: The objective of this study was to investigate whether ingestion of fructose and fructans (such as inulin) can exacerbate irritable bowel syndrome (IBS) symptoms. The aim was to better understand the origin of these symptoms by magnetic resonance imaging (MRI) of the gut.

Methods: A total of 16 healthy volunteers participated in a four-way, randomized, single-blind, crossover study in which they consumed 500 ml of water containing 40 g of either glucose, fructose, inulin, or a 1:1 mixture of 40 g glucose and 40 g fructose. MRI scans were performed hourly for 5 h, assessing the volume of gastric contents, small bowel water content (SBWC), and colonic gas. Breath hydrogen (H2) was measured and symptoms recorded after each scan.

Results: Data are reported as mean (s.d.) (95% CI) when normally distributed and median (range) when not. Fructose increased area under the curve (AUC) from 0-5 h of SBWC to 71 (23) l/min, significantly greater than for glucose at 36 (11-132) l/min (P<0.001), whereas AUC SBWC after inulin, 33 (17-106) l/min, was no different from that after glucose. Adding glucose to fructose decreased AUC SBWC to 55 (28) l/min (P=0.08) vs. fructose. Inulin substantially increased AUC colonic gas to 33 (20) l/min, significantly greater than glucose and glucose+fructose (both P<0.05). Breath H2 rose more with inulin than with fructose. Glucose when combined with fructose significantly reduced breath H2 by 7,700 (3,121-12,300) p.p.m./min relative to fructose alone (P<0.01, n=13).

Conclusions: Fructose but not inulin distends the small bowel with water. Adding glucose to fructose reduces the effect of fructose on SBWC and breath hydrogen. Inulin distends the colon with gas more than fructose, but causes few symptoms in healthy volunteers.

Figures

Figure 1
Figure 1
Breath hydrogen (H2) concentrations throughout the study day for the 13 H2 producers after drinking each of the four drinks: glucose, fructose, fructan, and glucose+fructose mix. The time of drinking (t=0 min) is highlighted in the chart. Values are mean concentration (p.p.m.)±s.e.m.
Figure 2
Figure 2
Small bowel water content (SBWC) throughout the study day for 16 volunteers after drinking each of the four drinks: glucose, fructose, fructan, and glucose+fructose mix. The time of drinking (t=0 min) is highlighted in the chart. Values are mean volume (ml)±s.e.m.
Figure 3
Figure 3
A representative example of coronal images of the small bowel from a single volunteer at 75 min after drinking each of the test drinks: (a) glucose, (b) fructose, (c) glucose+fructose, and (d) fructan. The stomach and gall bladder are also visualized in these images.
Figure 4
Figure 4
The comparison between small bowel water content (SBWC) for 8 subjects who produced hydrogen (H2 positive) after fructose and 8 who did not (H2 negative) after drinking (a) fructose and (b) glucose+fructose. Values are mean concentration (ml)±s.e.m.
Figure 5
Figure 5
A representative example of coronal images through the large bowel of a single volunteer, comparing the visibility of gas in the colon at (a) baseline t= −45 min and (b) 255 min after drinking the fructan test meal.
Figure 6
Figure 6
Colonic gas volumes through the study day for the volunteers. The time of drinking (t =0 min) is highlighted in the chart. Values are mean volume (ml)±s.e.m.
Figure 7
Figure 7
The percent change from baseline of the small bowel diameters (SBDs) of the volunteers. The time of drinking is highlighted in the chart. Values are mean percent change ±s.e.m.

References

    1. Francis CY, Whorwell PJ. Bran and irritable-bowel-syndrome - time for reappraisal. Lancet. 1994;344:39–40.
    1. Nanda R, James R, Smith H, et al. Food intolerance and the irritable bowel syndrome. Gut. 1989;30:1099–1104.
    1. Parker TJ, Naylor SJ, Riordan AM, et al. Management of patients with food intolerance in irritable bowel syndrome - the development and use of an exclusion diet. J Hum Nutr Diet. 1995;8:159–166.
    1. Staudacher HM, Whelan K, Irving PM, et al. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet. 2011;24:487–495.
    1. Staudacher HM, Lomer MCE, Anderson JL, et al. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr. 2012;142:1510–1518.
    1. Shepherd SJ, Parker FC, Muir JG, et al. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol. 2008;6:765–771.
    1. Shepherd SJ, Nut M, Gibson PR. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Am Diet Assoc. 2006;106:1631–1639.
    1. de Roest RH, Dobbs BR, Chapman BA, et al. The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study. Int J Clin Pract. 2013;67:895–905.
    1. Shepherd SJ, Lomer MCE, Gibson PR. Short-chain carbohydrates and functional gastrointestinal disorders. Am J Gastroenterol. 2013;108:707–717.
    1. Ong DK, Mitchell SB, Barrett JS, et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol. 2010;25:1366–1373.
    1. Barrett JS, Gearry RB, Muir JG, et al. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther. 2010;31:874–882.
    1. Rumessen JJ, Gudmand-Hoyer E. Fructans of chicory: intestinal transport and fermentation of different chain lengths and relation to fructose and sorbitol malabsorption. Am J Clin Nutr. 1998;68:357–364.
    1. Marciani L, Cox EF, Hoad CL, et al. Postprandial changes in small bowel water content in healthy subjects and patients with irritable bowel syndrome. Gastroenterology. 2010;138:469–U90.
    1. Rumessen JJ, Gudmandhoyer E. Absorption capacity of fructose in healthy adults-comparison with sucrose and its constituent monosaccharides. Gut. 1986;27:1161–1168.
    1. Truswell AS, Seach JM, Thorburn AW. Incomplete absorption of pure fructose in healthy subjects and the facilitating effect of glucose. Am J Clin Nutr. 1988;48:1424–1430.
    1. Parker K, Salas M, Nwosu VC. High fructose corn syrup: production, uses and public health concerns. Biotechnol Mol Biol Rev. 2010;5:71–78.
    1. Christopher NL, Bayless TM. Role of the small bowel and colon in lactose-induced diarrhea. Gastroenterology. 1971;60:845–852.
    1. Placidi E, Marciani L, Hoad CL, et al. The effects of loperamide, or loperamide plus simethicone, on the distribution of gut water as assessed by MRI in a mannitol model of secretory diarrhoea. Aliment Pharmacol Ther. 2012;36:64–73.
    1. van den Bogert B, de Vos WM, Zoetendal EG, et al. Microarray analysis and barcoded pyrosequencing provide consistent microbial profiles depending on the source of human intestinal samples. Appl Environ Microbiol. 2011;77:2071–2080.
    1. Hoad CL, Marciani L, Foley S, et al. Non-invasive quantification of small bowel water content by MRI: a validation study. Phys Med Biol. 2007;52:6909–6922.
    1. Jones HF, Butler RN, Brooks DA. Intestinal fructose transport and malabsorption in humans. Am J Physiol Gastrointest Liver Physiol. 2011;300:G202–G206.
    1. Gouyon F, Caillaud L, Carriere V, et al. Simple-sugar meals target GLUT2 at enterocyte apical membranes to improve sugar absorption: a study in GLUT2-null mice. J Physiol London. 2003;552:823–832.
    1. Rumessen JJ, Bode S, Hamberg O, et al. Fructans of Jerusalem artichokes - intestinal transport, absorption, fermentation and influence on blood glucose, insulin and c-peptide responses in healthy subjects. Am J Clin Nutr. 1990;52:675–681.
    1. Cherbut C. Inulin and oligofructose in the dietary fibre concept. Br J Nutr. 2002;87:S159–S162.
    1. Bond JH, Levitt MD. Investigation of small bowel transit-time in man utilizing pulmonary hydrogen (H2) measurements. J Lab Clin Med. 1975;85:546–555.
    1. Roberfroid MB. Caloric value of inulin and oligofructose. J Nutr. 1999;129:1436S–1437S.
    1. Spiller RC, Jones BJM, Silk DBA. Jejunal water and electrolyte absorption from 2 proprietary enteral feeds in man-importance of sodium content. Gut. 1987;28:681–687.
    1. Douard V, Ferraris RP. Regulation of the fructose transporter GLUT5 in health and disease. Am J Physiol Endocrinol Metabol. 2008;295:E227–E237.
    1. Wasserman D, Hoekstra JH, Tolia V, et al. Molecular analysis of the fructose transporter gene (GLUT5) in isolated fructose malabsorption. J Clin Invest. 1996;98:2398–2402.
    1. Roberfroid MB. Inulin-type fructans: functional food ingredients. J Nutr. 2007;137:2493S–2502S.
    1. Koide A, Yamaguchi T, Odaka T, et al. Quantitative analysis of bowel gas using plain abdominal radiograph in patients with irritable bowel syndrome. Am J Gastroenterol. 2000;95:1735–1741.
    1. Morken MH, Berstad AE, Nysaeter G, et al. Intestinal gas in plain abdominal radiographs does not correlate with symptoms after lactulose challenge. Eur J Gastroenterol Hepatol. 2007;19:589–593.
    1. Youn YH, Park JS, Jahng JH, et al. Relationships among the lactulose breath test, intestinal gas volume, and gastrointestinal symptoms in patients with irritable bowel syndrome. Dig Dis Sci. 2011;56:2059–2066.
    1. Harder H, Serra J, Azpiroz F, et al. Intestinal gas distribution determines abdominal symptoms. Gut. 2003;52:1708–1713.
    1. Spiller R. New insights into bloating and abdominal distension: is it all outlet obstruction. Am J Gastroenterol. 2010;105:888–889.

Source: PubMed

3
Prenumerera